/Moderna%20Inc%20meds-by%20Ascannio%20via%20Shutterstock.jpg)
Based in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a pioneering biotechnology company and a global leader in mRNA therapeutics and vaccines. With a market cap of $51.07 billion, Moderna has revolutionized the pharmaceutical industry by leveraging its innovative mRNA technology to develop treatments for a wide range of diseases. As a major player in the biotech industry, Moderna competes fiercely with companies like Pfizer Inc. (PFE), which is known for its extensive pharmaceutical and vaccine portfolios.
Companies valued at $10 billion or more are generally considered "large-caps," and Moderna fits this criterion perfectly, signifying its substantial size, stability, and influence in the biotechnology industry. Renowned for its groundbreaking mRNA technology and swift development of the COVID-19 vaccine, MRNA is at the forefront of biopharmaceutical innovation.